A low molecular weight folate receptor targeted contrast agent for magnetic resonance tumor imaging.
about
Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane ProteinsCritical design issues in the targeted molecular imaging of cell surface receptors.Facile Synthesis of Folic Acid-Modified Iron Oxide Nanoparticles for Targeted MR Imaging in Pulmonary Tumor Xenografts.Combined elemental and biomolecular mass spectrometry imaging for probing the inventory of tissue at a micrometer scale.Elemental imaging of MRI contrast agents: benchmarking of LA-ICP-MS to MRI.Pathway of cytotoxicity induced by folic acid modified selenium nanoparticles in MCF-7 cells.Dynamic contrast-enhanced optical imaging of in vivo organ function.Targeted delivery of gold nanoparticle contrast agents for reporting gene detection by magnetic resonance imagingStrategies for Target-Specific Contrast Agents for Magnetic Resonance ImagingSynthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR molecular imaging of prostate cancer.MRI of ovarian masses.Nanomedicine therapeutics and diagnostics are the goal.Comparative in vitro studies of MR imaging probes for metabotropic glutamate subtype-5 receptor targeting.MR molecular imaging of prostate cancer with a small molecular CLT1 peptide targeted contrast agent.Reprogramming of hepatic fat accumulation and 'browning' of adipose tissue by the short-chain fatty acid acetate.
P2860
Q28077999-F62A4B0A-83D5-4BF7-BD8E-0486BD150028Q30899036-8F138489-AC1C-4969-944C-6E6706612E86Q31029465-787585F7-13A2-4FE3-B48D-5D706E9E10D5Q34194137-EB688E65-8A55-4EFA-BD59-DF705EE193C8Q34242694-20304DBD-7614-417C-B12B-1F22E2669F67Q34402275-55202A35-1153-43E9-BE7D-642DCDA6BE45Q36210818-1D7C81E3-14FF-4F66-8ABF-F27C6BB444D2Q36372692-2D05AFC6-CE96-4AF9-8EB6-AA987ABE67CBQ36517070-B20E6853-5998-458C-A8B9-28EAF06AD03CQ36555396-55897D58-AF05-475A-87B5-DDDDB4DA058CQ38077164-52B18831-F36D-494D-B2F4-B79A3D0D28E7Q38842812-C3447A1E-C33D-4DB3-BEE9-531AC69436A3Q39113752-59A02032-6095-4127-BA2C-7F52288D3C19Q42829048-BE543C74-3B77-4043-B28A-4C6743B2B040Q52880767-A9ECA8F9-22A9-436D-860C-B218EC2ED06A
P2860
A low molecular weight folate receptor targeted contrast agent for magnetic resonance tumor imaging.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A low molecular weight folate ...... netic resonance tumor imaging.
@ast
A low molecular weight folate ...... netic resonance tumor imaging.
@en
type
label
A low molecular weight folate ...... netic resonance tumor imaging.
@ast
A low molecular weight folate ...... netic resonance tumor imaging.
@en
prefLabel
A low molecular weight folate ...... netic resonance tumor imaging.
@ast
A low molecular weight folate ...... netic resonance tumor imaging.
@en
P2093
P2860
P1476
A low molecular weight folate ...... netic resonance tumor imaging.
@en
P2093
Andrew D Miller
Cameron W McLeod
Jimmy D Bell
John A Pugh
Josephine Bunch
Michael R Jorgensen
Nazila Kamaly
Tammy L Kalber
P2860
P2888
P304
P356
10.1007/S11307-010-0400-3
P577
2011-08-01T00:00:00Z